Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,680 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 601 of 640 · 7,680 filings

  • Pegasystems (PEGA) FY2024 10-K risk factors
    38 risks

    Subscription revenue dominates, making retention, scalable delivery, pricing, and predictable cloud/license timing central risks.

    Filed Feb 12, 2025
  • Westinghouse Air Brake Technologies (WAB) FY2024 10-K risk factors
    31 risks

    Global rail and transit demand, major customers, and supply-chain execution dominate Wabtec’s risk profile.

    Filed Feb 12, 2025
  • Verizon Communications (VZ) FY2024 10-K risk factors
    17 risks

    5G deployment, network resilience and cybersecurity dominate Verizon’s operational risks.

    Filed Feb 12, 2025
  • American Assets Trust (AAT) FY2024 10-K risk factors
    61 risks

    Company faces heavy geographic concentration in California, Washington, Oregon, Texas, and Hawaii. Office properties generated 53 percent of net operating income in 2024. Total debt stood at 1.70 billion dollars as of February 11, 2025.

    Filed Feb 12, 2025
  • Ares Commercial Real Estate (ACRE) FY2024 10-K risk factors
    98 risks

    Portfolio concentration in office and mixed-use properties drives credit risks and CECL reserve increases. Heavy reliance on debt financing and credit agreements creates collateral and liquidity exposure. External management by Ares creates information system and operational dependencies.

    Filed Feb 12, 2025
  • Albemarle (ALB) FY2024 10-K risk factors
    52 risks

    Lithium demand and market price volatility heavily dominate Albemarle's risk profile alongside significant exposure to Chinese regulatory and political shifts.

    Filed Feb 12, 2025
  • Alkermes (ALKS) FY2024 10-K risk factors
    42 risks

    Alkermes relies heavily on commercial sales of proprietary neuroscience products like VIVITROL, ARISTADA, and LYBALVI. The company faces significant intellectual property, pricing, and manufacturing compliance risks.

    Filed Feb 12, 2025
  • Antero Midstream (AM) FY2024 10-K risk factors
    50 risks

    Substantially all revenue depends on a single customer, Antero Resources, creating severe operational and credit concentration risks. Operations are geographically concentrated in the Appalachian Basin and subject to extensive federal and state environmental, climate, and wildlife regulations. Extensive debt obligations and capital expenditure requirements depend heavily on continued access to favorable credit and capital markets.

    Filed Feb 12, 2025
  • American Well (AMWL) FY2024 10-K risk factors
    67 risks

    Significant ongoing net losses and accumulated deficit raise substantial going concern doubts. Heavy customer concentration with Elevance creates severe revenue vulnerability. Complex regulatory healthcare environment and medical liability risks threaten operations.

    Filed Feb 12, 2025
  • ANTERO Resources (AR) FY2024 10-K risk factors
    60 risks

    Antero Resources faces concentrated geographic risks in the Appalachian Basin and heavy exposure to commodity price volatility for natural gas, NGLs, and oil.

    Filed Feb 12, 2025
  • Armour Residential REIT (ARR) FY2024 10-K risk factors
    71 risks

    Armour Residential REIT faces substantial interest rate, financing, and counterparty risks, heavily reliant on repurchase agreements and manager ACM.

    Filed Feb 12, 2025
  • Biogen (BIIB) FY2024 10-K risk factors
    34 risks

    Heavy reliance on key product revenues and anti-CD20 therapeutic programs in competitive markets.

    Filed Feb 12, 2025

Companies covered

4,010 companies

371 more under A